Big decisions demand the best tech-driven solutions. Learn More

Close this search box.
CMS Proposed Rule

Home » Blogs 

CMS Proposed Rule for 2025 MA, Prescription Drug Plans

The Centers for Medicare & Medicaid Services (CMS) recently unveiled a comprehensive CMS proposed rule for the 2025 Medicare Advantage (MA) and Prescription Drug Plans. This pivotal move aims to revolutionize the landscape of healthcare for Medicare beneficiaries. The CMS proposed rule encompasses many changes, focusing on enhancing health equity, safeguarding Medicare beneficiaries, and expanding access to crucial behavioral health services.

Understanding the CMS Proposed Rule

At the heart of the CMS proposed rule is a commitment to improving the overall quality and accessibility of healthcare services for Medicare recipients. This rule is not just a policy change; it’s a significant step towards a more equitable and efficient healthcare system.

Key Changes in the CMS Proposed Rule

  • Agent and Broker Compensation: The CMS proposed rule brings attention to the changes in compensation structures for agents and brokers. The main objective of the rule is to eliminate any biases in plan selection by standardizing compensation. This will ensure that beneficiaries enroll in plans best suited to their needs.
  • Supplemental Benefits: The CMS proposed rule strongly emphasizes additional benefits. MA plans must notify beneficiaries about unused extra benefits, ensuring that these benefits are utilized effectively and not merely as marketing tools.
  • Health Equity and Prior Authorization: A groundbreaking element of the CMS proposed rule is introducing an annual health equity analysis. The analysis focuses on the impact of prior authorization policies on enrollees, particularly those with social risk factors.
  • Behavioral Health Services: The CMS proposed rule proposes including a new facility specialty type, ‘Outpatient Behavioral Health’. This inclusion is a strategic move to enhance access to a broad spectrum of behavioral health services.
  • Streamlining Processes: The rule also seeks to streamline various processes, including the appeals process for MA Risk Adjustment Data Validation audit findings and the enrollment process for individuals eligible for Medicare and Medicaid.
  • Flexibility for Part D Plans: In a significant move, the CMS proposed rule offers more flexibility to Part D plans in substituting biosimilars for reference drug products, potentially leading to cost savings and increased accessibility to essential medications.

The Impact of the CMS Proposed Rule

The CMS proposed rule is poised to bring about transformative changes in the Medicare Advantage and Prescription Drug Plans. The rule addresses long-standing healthcare access and quality disparities by focusing on health equity. The standardized compensation for agents and brokers and the emphasis on supplemental benefits align intending to ensure that Medicare beneficiaries receive comprehensive and unbiased information when selecting their healthcare plans.

Looking Ahead with RAAPID

As we look toward implementing the CMS proposed rule in 2025, it’s clear that these changes are a step in the right direction for Medicare Advantage and Prescription Drug Plans. The focus on health equity, behavioral health services, and streamlined processes underscores a commitment to enhancing the healthcare experience for Medicare beneficiaries.

Adapting to these changes is crucial for healthcare organizations, especially those participating in Medicare Advantage, Managed Medicaid, ACA commercial, and Medicare ACO programs. RAAPID, a healthcare technology company, stands ready to assist. Our platform, powered by AI, ML, NLP, and knowledge graphs, is designed to help organizations transition smoothly to value-based care. With RAAPID’s cloud-based Risk Adjustment applications, healthcare organizations can efficiently manage structured and unstructured patient data, ensuring accurate chronic condition extraction, risk score calculations, and gap analysis in care. Our solutions are tailored to drive revenue, reduce administrative costs, and enable organizations to operate virtually anywhere, anytime.

To learn more about the CMS proposed rule for 2025, visit CMS’s official fact sheet.

The CMS proposed rule for 2025 is a testament to the ongoing efforts to improve healthcare for Medicare beneficiaries. As we move closer to its implementation, RAAPID ensures that your organization is well-equipped to adapt and thrive in this evolving landscape.


Lastest Posts

Subscribe To Our Newsletter

This field is for validation purposes and should be left unchanged.

Disclaimer: All the information, views, and opinions expressed in this blog are inspired by Healthcare IT industry trends, guidelines, and their respective web sources and are aligned with the technology innovation, products, and solutions that RAAPID offers to the Risk adjustment market space in the US.